Skip to main content
Premium Trial:

Request an Annual Quote

Full Genome Sequences: It's Been a Good Run -- Is It Over?

Omics! Omics! offers a thoughtful post on the era of full genome sequencing. Blogger Keith Robison considers the decade-old field, noting some of its successes and excitement -- and taking a moment to lay out some of the missing pieces among sequenced organisms.

He also refers to a post at the Evolgen blog, which published the rumor that NHGRI will no longer be accepting white papers to sequence full genomes. While there's no definitive answer on the NHGRI's stance, the post did spark a lively conversation on the merit of finished genome sequences and the state of funding.

 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.